AcelRx Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ACRX and buy or sell other stocks, ETFs, and their options commission-free!About ACRX
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03.
CEOVincent J. Angotti, MBA
CEOVincent J. Angotti, MBA
Employees13
Employees13
HeadquartersSan Mateo, California
HeadquartersSan Mateo, California
Founded2005
Founded2005
Employees13
Employees13
ACRX Key Statistics
Market cap39.20M
Market cap39.20M
Price-Earnings ratio-3.33
Price-Earnings ratio-3.33
Dividend yield—
Dividend yield—
Average volume327.29K
Average volume327.29K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.57
52 Week high$1.57
52 Week low$0.38
52 Week low$0.38
Stock Snapshot
With a market cap of 39.2M, AcelRx Pharmaceuticals(ACRX) trades at $0.86. The stock has a price-to-earnings ratio of -3.33.
On 2025-12-05, AcelRx Pharmaceuticals(ACRX) stock opened at —, reached a high of —, and a low of —.
The AcelRx Pharmaceuticals(ACRX)'s current trading volume is 0, compared to an average daily volume of 327.29K.
In the last year, AcelRx Pharmaceuticals(ACRX) shares hit a 52-week high of $1.57 and a 52-week low of $0.38.
In the last year, AcelRx Pharmaceuticals(ACRX) shares hit a 52-week high of $1.57 and a 52-week low of $0.38.
People also own
Based on the portfolios of people who own ACRX. This list is generated using Robinhood data, and it’s not a recommendation.